However, Li et al. showed that patients with p53 72Arg/Pro and the combined p53 72Arg/Pro + Pro/Pro genotypes exhibited a significantly greater risk of SPMs in a cohort of 1271 HNSCC patients, compared with p53 72Arg/Arg genotype (51). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.